The Medicines and Healthcare Products Regulatory Agency (MHRA) revealed in association with the use of GLP-1RA receptor agonist drugs such as Mounjaro, Wegovy and Ozempic, up to January 31.

Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.

There is a donated kidney shortage in the U.S. It’s leaving more than 100,000 people on a years-long waitlist. And despite ...

An approval for the first drug for a rare lipid storage disease, some FDA workers rehired, and other biotech news of the day ...

Type C Meeting Requested to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, Feb. 24, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc.